EnVVeno Medical Q4 EPS $(0.32) Beats $(0.46) Estimate
EnVVeno Medical Q4 EPS $(0.32) Beats $(0.46) Estimate
EnvVeno Medical第四季度每股收益美元（0.32）超过预期（0.46）
enVVeno Medical (NASDAQ:NVNO) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.46) by 30.43 percent. This is a 41.82 percent increase over losses of $(0.55) per share from the same period last year.
EnvVeno Medical（纳斯达克股票代码：NVNO）公布的季度亏损为每股0.32美元，比分析师共识估计的美元（0.46美元）高出30.43个百分点。这比去年同期每股亏损0.55美元（0.55）增长了41.82％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。